HBOT Conversations:
Dr. Paul Harch & Inflammation
Dr. Paul G. Harch, M.D. has used hyperbaric oxygen therapy to treat more than 100 different conditions, including stroke, dementia, autism, and traumatic brain injury. His goal is to help his patients get their lives back using hyperbaric oxygen therapy.
He is the author of The Oxygen Revolution and is considered an International expert and pioneer in the field of Hyperbaric Oxygen Therapy (HBOT). His informative, and comprehensive guide on HBOT has helped countless souls better understand what HBOT is and how it directly affects the body at the genetic level.
This episode on Inflammation is the first in a 9 episode series that will be released weekly with Dr. Harch.
Watch the Podcast
HBOT News podcast host, Edward di Girolamo, talks with special guest and HBOT expert, Dr. Paul G. Harch, MD. This is the first of nine episodes with Dr. Harch examining the God-given miracle of Hyperbaric Oxygen Therapy.
In this episode, we dive into how HBOT is a game-changer for inflammation. Harch explains that inflammation is the driving factor for countless chronic illnesses, but thankfully Hyperbaric Oxygen Therapy is a natural proven way to suppress inflammation.
Harch summarizes a fascinating study done in 2008, by Dr. Cassandra Godman. Her team took skin biopsies and extracted the normal tissue, then they examined the cells that lined the tiniest blood vessels in the tissue. Next, they put these cells in a petri dish and put them in a hyperbaric chamber and gave him a single hyperbaric treatment. Afterwards, they did a mass gene array analysis for 48 hours. What happened next was ground-breaking in better understanding the role that HBOT has on inflammation.
At the end of 24 hours 8,101 of our 19,000 protein coding genes in our 23 chromosomes were either significantly turned on or turned off & suppressed. That single HBOT treatment turned on the anti-inflammatory genes and the growth and repair hormone genes, and the largest cluster suppressed were the pro-inflammatory genes.
Our inflammatory reaction is inescapable when an injury occurs. But, when the patient receives hyperbaric oxygen therapy treatment after an injury (the sooner the better), it can have an overwhelming positive influence on the inflammatory reaction at any place along the spectrum. Harch continues to explain that the anti-inflammatory effects of hyperbaric oxygen are wide-ranging.
Harch spoke of the Navy’s experience with Hyperbaric Oxygen Therapy, as the Navy really kind of dominated this field for many years. The Navy reported that if you can get someone in a chamber within one hour of coming out of the water – when they’re symptomatic for decompression sickness – then the first hyperbaric treatment is curative in 90% of cases. Everyone thought that HBOT was treating bubbles in the brain at that point, but the reality is they were treating inflammation. We now know that it’s the inflammatory reaction in the brain after the bubbles passed that Hyperbaric Oxygen Therapy is treating; not the bubbles.
HBOT isn’t new, it dates back well over a hundred years. It’s still misunderstood, because many believe that HBOT therapy is a treatment for diseases. But, the reality is that HBOT is a treatment for disease processes, and it’s these processes that cause the diseases. We treat the inflammation that causes the disease processes, and in turn we treat the disease. That’s the power of Hyperbaric Oxygen Therapy.
Stay tuned for all nine episodes that will be release each Friday for the next eight weeks.
Guest
Dr. Paul G. Harch, MD
Dr. Paul G. Harch, M.D. is a clinician in emergency medicine and hyperbaric medicine who is the former director of the University Medical Center Hyperbaric Medicine Department and LSU Hyperbaric Medicine Fellowship. Currently, he is a Clinical Professor of Medicine in the Section of Emergency Medicine at LSU School of Medicine in New Orleans. He graduated from the Johns Hopkins University School of Medicine after graduating from the University of California at Irvine with magna cum laude/Phi Beta Kappa honors.
Dr. Harch initiated and continues to be a private practice that has resulted in the largest case experience in neurological hyperbaric medicine in the world. In this practice, he adapted the concepts of conventional hyperbaric oxygen therapy to wounds in the central nervous system, which spawned the subsequent academic and research practice. Harch HBOT is the best place to receive oxygen therapy treatments, and patients have traveled from more than 50 countries to be treated by Dr. Harch himself.
Harch HBOT – Hyperbaric Oxygen Therapy Clinic
5216 Lapalco Blvd.
Marrero, LA
504-309-4948
hbot@hbot.com
https://hbot.com/
Subscribe Now, It’s Free !
Recent HBOT News
Growth Hormone Deficiency: Health and Longevity
Abstract The important role of GH in the control of mammalian longevity was first deduced from extended longevity of mice with genetic GH deficiency (GHD) or GH resistance. Mice with isolated GHD (IGHD) due to GHRH or GHRH receptor mutations, combined deficiency of...
Why is Justin Bieber Sleeping in a hyperbaric Oxygen Chamber?
Find out why pop star Justin Beiber has decided to sleep in a hyperbaric oxygen chamber. "Justin Bieber is testing out some futuristic healing technology. The pop star, 25, showed fans his new nighttime routine on his Instagram Stories on Sunday, passing his phone off...
Clinical Trial – The Role of Hyperbaric Oxygen and Neuropsychological Therapy in Cognitive Function Following Traumatic Brain Injury
Traumatic brain injury (TBI) caused by accidents is a very important public health problem in
Taiwan. There are many people with brain damage and cognitive dysfunction caused by traumatic
brain injury every year. Currently, there is no effective treatment for cognitive dysfunction
caused by traumatic brain injury. Evidence from clinical studies in recent years suggests
that hyperbaric oxygen therapy may be a treatment for repairing nerves after brain injury.
Many studies have shown that oxidative stress and inflammatory responses play an important
role in the pathogenesis of the central nervous system. In recent years, our research team
has shown that oxidative stress and inflammatory response are significantly associated with
the prognosis of patients with traumatic brain injury, cerebral hemorrhage, and stroke
patients. More and more evidences also show that oxidative stress and inflammatory response
play an important role in the neuropathological changes of mental cognitive sequelae after
traumatic brain injury. This injury may be gradual from the time of head trauma. This process
begins with the generation of oxidative stress and free radicals. When the cell repair and
free radical scavenging system can not effectively overcome the excessive production of free
radicals, an oxidative damage reaction will occur, causing a series of inflammatory cells and
cytokines to be activated. Studies have also shown that when inhibiting those free radicals
that produce oxidative stress, the neurological function and cognitive function of the head
after trauma can be significantly improved.
It is becoming widely acknowledged that the combined action of hyperoxia and hyperbaric
pressure leads to significant improvement in tissue oxygenation while targeting both
oxygenand pressure-sensitive genes, resulting in improved mitochondrial metabolism with
anti-apoptotic and anti-inflammatory effects. The investigators published an article this
year showing that hyperbaric oxygen therapy can improve the prognosis of patients with acute
stroke and increase endothelial progenitor cells in the systemic circulation.
The investigators plan to conduct this research project through hyperbaric oxygen therapy and
neuropsychological therapy, and using scientific tests and neurocognitive function
assessments. The investigators hope to answer the following questions: (1) Whether the
treatment of hyperbaric oxygen can improve oxidative stress and inflammatory response after
brain injury, and observe changes in biomarker concentration; (2) Whether hyperbaric oxygen
therapy and neuropsychological therapy can improve cognitive function after brain injury; and
(3) which biomarkers are factors that influence cognitive function prognosis.